E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research

Online Publishing Date:
24 / 09 / 2018

 


A study on the effect of duration of Type 2 diabetes mellitus on nerve conduction velocity

Chethan K, Sowjanya T.


Abstract
Background: Diabetic polyneuropathy, the most common type of neuropathy observed results from microvascular injury leading to damage of the nerve. Diabetic neuropathy depends on both duration as well as on the level of control of blood sugars. It depends more on the duration of diabetes.

Aims and Objectives: This study was done to see the effect of duration of Type 2 diabetes on median nerve conduction velocity (NCV).

Materials and Methods: A total of 100 subjects were taken, 50 patients of Type 2 diabetes mellitus with duration of 5 years or more and another 50 patients with duration of diabetes being <5 years. The entire recording was done using a four channel ADInstrument and compound muscle action potential were recorded using the LabChart software in both the groups.

Results: We found that there was a significant (P < 0.05) decrease in the NCV among the diabetic population 5 years or more (45.01 ± 17.18) compared to the <5 years (51.55 ± 15.52). There was a non-significant change in the amplitude (P > 0.05) among the diabetic population 5 years or more (487.35 ± 60.74) compared to <5 years (536.19 ±63.88). There was a non-significant change in the distal latency (P > 0.05) among the diabetic duration of 5 years or more (0.00475 ± 0.0015) compared to <5 years of diabetes (0.004602 ± 0.0015).

Conclusion: Thus, from our study we would like to conclude that there is a link between the duration of diabetes and NCV.

Key words: Diabetes Mellitus; Nerve Conduction Velocity; Neuropathy


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Chethan K
Articles by Sowjanya T
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

K C, T S. A study on the effect of duration of Type 2 diabetes mellitus on nerve conduction velocity. Natl J Physiol Pharm Pharmacol. 2018; 8(12): 1622-1624. doi:10.5455/njppp.2018.8.0928920092018


Web Style

K C, T S. A study on the effect of duration of Type 2 diabetes mellitus on nerve conduction velocity. https://www.njppp.com/?mno=7906 [Access: March 15, 2024]. doi:10.5455/njppp.2018.8.0928920092018


AMA (American Medical Association) Style

K C, T S. A study on the effect of duration of Type 2 diabetes mellitus on nerve conduction velocity. Natl J Physiol Pharm Pharmacol. 2018; 8(12): 1622-1624. doi:10.5455/njppp.2018.8.0928920092018



Vancouver/ICMJE Style

K C, T S. A study on the effect of duration of Type 2 diabetes mellitus on nerve conduction velocity. Natl J Physiol Pharm Pharmacol. (2018), [cited March 15, 2024]; 8(12): 1622-1624. doi:10.5455/njppp.2018.8.0928920092018



Harvard Style

K, C. & T, . S. (2018) A study on the effect of duration of Type 2 diabetes mellitus on nerve conduction velocity. Natl J Physiol Pharm Pharmacol, 8 (12), 1622-1624. doi:10.5455/njppp.2018.8.0928920092018



Turabian Style

K, Chethan, and Sowjanya T. 2018. A study on the effect of duration of Type 2 diabetes mellitus on nerve conduction velocity. National Journal of Physiology, Pharmacy and Pharmacology, 8 (12), 1622-1624. doi:10.5455/njppp.2018.8.0928920092018



Chicago Style

K, Chethan, and Sowjanya T. "A study on the effect of duration of Type 2 diabetes mellitus on nerve conduction velocity." National Journal of Physiology, Pharmacy and Pharmacology 8 (2018), 1622-1624. doi:10.5455/njppp.2018.8.0928920092018



MLA (The Modern Language Association) Style

K, Chethan, and Sowjanya T. "A study on the effect of duration of Type 2 diabetes mellitus on nerve conduction velocity." National Journal of Physiology, Pharmacy and Pharmacology 8.12 (2018), 1622-1624. Print. doi:10.5455/njppp.2018.8.0928920092018



APA (American Psychological Association) Style

K, C. & T, . S. (2018) A study on the effect of duration of Type 2 diabetes mellitus on nerve conduction velocity. National Journal of Physiology, Pharmacy and Pharmacology, 8 (12), 1622-1624. doi:10.5455/njppp.2018.8.0928920092018